Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cricoid Cartilage | 1 | 2020 | 1 | 0.650 |
Why?
|
| Laryngostenosis | 1 | 2020 | 2 | 0.650 |
Why?
|
| Cartilage Diseases | 1 | 2020 | 5 | 0.640 |
Why?
|
| Tracheostomy | 1 | 2020 | 7 | 0.640 |
Why?
|
| Orbital Fractures | 1 | 2019 | 6 | 0.640 |
Why?
|
| Haemophilus Infections | 1 | 2020 | 29 | 0.630 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 28 | 0.630 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 35 | 0.630 |
Why?
|
| Streptococcal Infections | 1 | 2020 | 37 | 0.630 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2019 | 72 | 0.590 |
Why?
|
| Warfare | 1 | 2026 | 10 | 0.240 |
Why?
|
| Health Personnel | 1 | 2026 | 96 | 0.230 |
Why?
|
| Mycobacterium chelonae | 1 | 2021 | 4 | 0.180 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 6 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2020 | 2635 | 0.170 |
Why?
|
| Blepharoplasty | 1 | 2020 | 3 | 0.170 |
Why?
|
| Blepharoptosis | 1 | 2020 | 7 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2020 | 29 | 0.170 |
Why?
|
| Adult | 5 | 2020 | 8026 | 0.170 |
Why?
|
| Male | 7 | 2026 | 13931 | 0.170 |
Why?
|
| Respiratory Sounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Laryngoscopy | 1 | 2020 | 6 | 0.160 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 5 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 6 | 0.160 |
Why?
|
| Dyspnea | 1 | 2020 | 25 | 0.160 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 27 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 40 | 0.160 |
Why?
|
| Necrosis | 1 | 2020 | 85 | 0.160 |
Why?
|
| Prosthesis Design | 1 | 2019 | 88 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 536 | 0.150 |
Why?
|
| Alcoholism | 1 | 2020 | 121 | 0.150 |
Why?
|
| Depression | 1 | 2020 | 225 | 0.140 |
Why?
|
| Humans | 8 | 2026 | 28870 | 0.120 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2015 | 20 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2015 | 10 | 0.110 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 22 | 0.110 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 16 | 0.110 |
Why?
|
| Female | 6 | 2026 | 15631 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 93 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 136 | 0.100 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2013 | 13 | 0.100 |
Why?
|
| Laparotomy | 1 | 2013 | 35 | 0.100 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 35 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 191 | 0.100 |
Why?
|
| Ukraine | 1 | 2026 | 1 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 2426 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2026 | 124 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 7415 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 995 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2026 | 1000 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2021 | 108 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 5598 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 2835 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 22 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 75 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 102 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2015 | 26 | 0.030 |
Why?
|
| Thrombelastography | 1 | 2015 | 47 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 237 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 131 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 159 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2015 | 125 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 612 | 0.030 |
Why?
|
| Fasciotomy | 1 | 2013 | 2 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2013 | 7 | 0.020 |
Why?
|
| Resuscitation | 1 | 2013 | 59 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 347 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1032 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 481 | 0.020 |
Why?
|
| United States | 1 | 2015 | 2223 | 0.020 |
Why?
|